Back to Search Start Over

Hyperglycemia potentiates the effect of ionic calcium in photoreceptor ellipsoid zone disruption in diabetic retinopathy.

Authors :
Ankita
Stefanickova J
Saxena S
Nim DK
Ahmad K
Mahdi AA
Kaur A
Bhasker SK
Valaskova J
Kruzliak P
Source :
International ophthalmology [Int Ophthalmol] 2019 Oct; Vol. 39 (10), pp. 2237-2243. Date of Electronic Publication: 2019 Jan 09.
Publication Year :
2019

Abstract

Purpose: To study the association of serum ionic calcium and glycated hemoglobin (HbA1c) with retinal photoreceptor ellipsoid zone (EZ) disruption in diabetic retinopathy (DR).<br />Methods: This is a tertiary care center-based observational cross-sectional study. Sixty-three consecutive cases, divided into 21 cases each with no diabetic retinopathy, non-proliferative diabetic retinopathy and proliferative diabetic retinopathy were included. Twenty-one healthy controls were also included. Ellipsoid zone disruption was assessed using spectral-domain optical coherence tomography. Serum ionic calcium and HbA1c were measured using standard protocol. Patient data from cases were divided into two groups according to their HbA1c levels: group 1 (HbA1c < 7, n = 26) and group 2 (HbA1c > 7, n = 37). Data were analyzed statistically.<br />Results: Mean ionic calcium levels in group 1 and group 2 were 1.131 ± 0.073 mmol/dL and 1.170 ± 0.070 mmol/dL, respectively. In group 1, 11 out of 26 had EZ disruption (42.3%). Similarly, in group 2, 29 out of 37 had EZ disruption (78.4%). On logistic regression analysis, as compared to group 1, ellipsoid zone disruption was found to be positively associated with serum ionic calcium (p = 0.01) in group 2 cases.<br />Conclusion: Increased levels of serum ionic calcium are associated with increased EZ disruption in patients with HbA1c > 7 in DR.

Details

Language :
English
ISSN :
1573-2630
Volume :
39
Issue :
10
Database :
MEDLINE
Journal :
International ophthalmology
Publication Type :
Academic Journal
Accession number :
30628026
Full Text :
https://doi.org/10.1007/s10792-018-01063-8